- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 31/165 - Amides, p. ex. acides hydroxamiques ayant des cycles aromatiques, p. ex. colchicine, aténolol, progabide
Détention brevets de la classe A61K 31/165
Brevets de cette classe: 3624
Historique des publications depuis 10 ans
|
223
|
242
|
249
|
245
|
279
|
270
|
261
|
214
|
225
|
162
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Regents of the University of California | 20172 |
48 |
| Newron Pharmaceuticals S.p.A. | 62 |
40 |
| Novartis AG | 10686 |
32 |
| Les Laboratoires Servier | 534 |
30 |
| LTS Lohmann Therapie-Systeme AG | 712 |
23 |
| Murray and Poole Enterprises Limited | 26 |
22 |
| Allergan, Inc. | 2321 |
20 |
| The General Hospital Corporation | 4784 |
19 |
| Axsome Malta Ltd. | 76 |
19 |
| President and Fellows of Harvard College | 6013 |
17 |
| Indiana University Research and Technology Corporation | 800 |
17 |
| Board of Regents, The University of Texas System | 5898 |
16 |
| BIAL - Portela & CA, S.A. | 225 |
16 |
| Vanda Pharmaceuticals, Inc. | 367 |
16 |
| Dana-Farber Cancer Institute, Inc. | 2604 |
15 |
| Bristol-myers Squibb Company | 4845 |
14 |
| Children's Medical Center Corporation | 1900 |
14 |
| Dompé Farmaceutici S.p.A. | 273 |
14 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2890 |
14 |
| The Trustees of the University of Pennsylvania | 4368 |
13 |
| Autres propriétaires | 3205 |